Labneaz Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 34.04%
- Profit Growth -3279.17%
- Ebitda -216.00%
- Net Worth -102.37%
- Total Assets 163.71%
About Labneaz Pharma
Labneaz Pharma Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 April 2013 and has a history of 11 years and nine months. Its registered office is in Budaun, Uttar Pradesh, India.
The Corporate was formerly known as Vestige Labs Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Feeroj and Kamni Rathaur serve as directors at the Company.
Company Details
-
Location
Budaun, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233UP2013PTC056273
-
Company No.
056273
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Apr 2013
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Labneaz Pharma Private Limited offer?
Labneaz Pharma Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Nutraceuticals & Dietary Supplements, Mineral Supplement, Common Disease Medicines, Pharmaceutical Tablets, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Sexual Wellness Products, Fertility Enhancer.
Who are the key members and board of directors at Labneaz Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Feeroj
|
Director | 18-Apr-2013 | Current |
|
Kamni Rathaur
|
Director | 18-Apr-2013 | Current |
Financial Performance of Labneaz Pharma.
Labneaz Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 34.04% increase. The company also saw a substantial fall in profitability, with a 3279.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 102.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Labneaz Pharma?
Unlock access to Labneaz Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Labneaz Pharma?
Unlock and access historical data on people associated with Labneaz Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Labneaz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labneaz Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.